| View |
|
BR-1196
|
Affinity-Purified Antibodies To Human Interferon Gamma
|
Anaferon
|
3 mg
|
Orodispersible Tablet
|
Prescription Drug (RX)
|
Alu/PVC blister pack x 20's (Box of 20's)
|
Immunostimulants
|
“NPF” Materia Medica Holding
|
Russia
|
N/A
|
Mega Lifesciences Limited Inc.
|
Metro Drug, Inc.
|
Initial
|
07 March 2022
|
22 November 2026
|
| View |
|
BR-1197
|
Menotrophin
|
Menopur
|
600 IU
|
Powder for Solution for Injection (SC)
|
Prescription Drug (RX)
|
Packaging: Each box contains: 2 mL Type I glass vial with halobutyl rubber stopper closed with a flip-off seal (Powder) + 1 mL Type I pre-filled glass syringe barrel with halobutyl plunger stopper (Water for Injection + Metacresol as diluent) + 1 separate needle for reconstitution + 9 disposable syringes
|
Gonadotropins
|
Ferring GmbH
|
Germany
|
N/A
|
Metro Drug, Inc.
|
Metro Drug, Inc.
|
Initial
|
09 February 2022
|
07 December 2026
|
| View |
|
BR-1198
|
Filgrastim
|
Zarzio
|
30 MU/0.5mL
|
Solution For Injection/Infusion (SC/IV)
|
Prescription Drug (RX)
|
0.5 mL in 1 mL Type I pre-filled glass syringe with grey bromobutyl plunger stopper and 27 Gy stainless steel needle with needle safety guard (Box of 5's)
|
Colony Stimulating Factors
|
Sandoz GmbH - Betriebsstätie / Manufacíuring Site
|
Austria
|
Sandoz GmbH
|
Sandoz Philippines Corporation
|
Sandoz Philippines Corporation
|
Initial
|
15 March 2022
|
15 December 2026
|
| View |
|
BR-1199
|
Clostridium Botulinum Type A Neurotoxin complex
|
Botox
|
50 Units
|
Powder for Solution for Injection (IM)
|
Prescription Drug (RX)
|
Type I colorless borosilicate glass vial with 13 mm
chlorobutyl rubber stopper, and an aluminum crimp seal fitted with polypropylene flip-off cap x 5 mL (Box of 1's)
|
-
|
Allergan Pharmaceuticals Ireland
|
Ireland
|
N/A
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
-
|
16 March 2022
|
13 January 2027
|
| View |
|
BR-1207
|
Vedolizumab
|
Entyvio
|
300 mg
|
Powder for Concentrate for Solution for
Infusion (IV)
|
Prescription Drug (RX)
|
20 mL Type I clear glass vial with rubber stopper aluminum seal with a white plastic flip-off cap (Box of 1's)
|
-
|
Takeda Pharmaceutical Company Limited (Hikari Plant)
|
Japan
|
Takeda Pharma A/S
|
Takeda Healthcare Philippines Inc.
|
N/A
|
Initial [from Monitored Release] (Reconstruction)
|
16 January 2024
|
24 February 2027
|
| View |
|
BR-1210
|
Idarucizumab
|
Praxbind
|
50mg/mL
|
Solution For Injection (IV)
|
Prescription Drug (RX)
|
50 mL Type I glass vial with butyl rubber stopper and
aluminum flip-off cap (Box of 2's)
|
-
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
N/A
|
Boehringer Ingelheim Philippines, Inc.
|
Boehringer Ingelheim Philippines, Inc.
|
-
|
22 April 2022
|
13 March 2027
|
| View |
|
BR-1215
|
Peginterferon alfa-2a
|
PEGNANO
|
180mcg/ 0.5 mL
|
Solution for S.C. Injection
|
Prescription Drug (Rx)
|
0.5 ml Pre-Filled Glass Syringe
|
IMMUNOSTIMULANT
|
Nanogen Pharmaceutical Biotechnology Co. Ltd
|
Vietnam
|
NANOGEN PHARMACEUTICAL BIOTECHNOLOGY CO., LTD.
|
AMBICA INTERNATIONAL CORPORATION
|
AMBICA INTERNATIONAL CORPORATION
|
Automatic Renewal
|
24 January 2022
|
02 May 2027
|
| View |
|
BR-1216
|
RECOMBINANT HUMAN ERYTHROPOIETIN
|
DYPOTIN
|
4000 IU/ mL (PRE-FILLED SYRINGE)
|
Solution for Injection
|
Prescription Drug (Rx)
|
PRE-FILLED SYRINGE
|
HEMATOPOIETIC GROWTH FACTOR
|
NCPC Genetech Biotechnology Co., Ltd
|
China
|
|
Dynasty Pharmaceuticals
|
DYNASTY PHARMACEUTICALS
|
Automatic Renewal
|
29 March 2022
|
09 May 2027
|
| View |
|
BR-1217
|
Streptokinase
|
None
|
1,500,000 IU
|
Powder For Injection (IV)
|
Prescription Drug (RX)
|
10 mL Clear vial (Box of l's and 10's)
|
-
|
Dae Han New Pharm. Co., LTD.
|
Korea
|
N/A
|
Britton Distribution Inc.
|
Britton Distribution Inc.
|
Renewal
|
27 October 2022
|
21 May 2026
|
| View |
|
BR-1218
|
Isophane Insulin Human
|
Insulatard
|
100 IU/mL
|
Solution for Injection (SC)
|
Prescription Drug (Rx)
|
Type I glass vial closed with a disc (bromobutyl/polyisoprene rubber) and a protective tamper-proof plastic cap containing 10 mL of suspension (Box of 1's)
|
Intermediate Acting Insulin
|
Novo Nordisk Production SAS
|
France
|
|
NOVO NORDISK PHARMACEUTICALS (PHILIPPINES) INC.
|
NOVO NORDISK PHARMACEUTICALS (PHILIPPINES) INC.
|
Automatic Renewal
|
26 March 2022
|
02 June 2027
|
| View |
|
BR-1219
|
Insulin Human (Regular)
|
Actrapid
|
100 IU/mL
|
Solution for Injection (SC)
|
Prescription Drug (Rx)
|
Type I glass vial closed with a disc (bromobutyl/polyisoprene rubber) and a protective tamper-proof plastic cap containing 10 mL of suspension (Box of 1's)
|
Short Acting Insulin
|
Novo Nordisk Production SAS
|
France
|
|
NOVO NORDISK PHARMACEUTICALS (PHILIPPINES) INC.
|
NOVO NORDISK PHARMACEUTICALS (PHILIPPINES) INC.
|
Automatic Renewal
|
31 March 2022
|
02 June 2027
|
| View |
|
BR-1214
|
Human Papillomavirus 9-Valent Vaccine (Recombinant,
Adsorbed)
|
Gardasil 9
|
Formulation: Each dose (0.5 mL) contains:
Human Papillomavirus Type 6 1.1-30 mcg protein Human Papillomavirus Type 11 1.1 protein-40 mcg
Human Papillomavirus Type 16 1.1 protein-60 mcg Human Papillomavirus Type 18 1.1 protein-40 mcg
Human Papillomavirus Type 31 1.1 protein-20 mcg
Human Papillomavirus Type 33 1.1 protein -20 mcg
Human Papillomavirus Type 45 1.1 protein -20 mcg
Human Papillomavirus Type 52 1.1 protein-20 mcg Human Papillomavirus Type 58 1.1 protein-20 mcg
Adsorbed on amorphous aluminum hydroxyphosphate sulphate adjuvant (500 mcg Al)
|
Suspension for Injection (IM)
|
Prescription Drug (RX)
|
Single dose. 0.5 mL in 3 mL Ph. Eur./USP Type I glass vial with Fluro TecTM-laminated stopper and aluminum seal with brown plastic flip-off cap [Box of 10's)
|
-
|
Merck Sharp & Dohme Corporation
|
United States of America
|
N/A
|
Merck Sharp & Dohme (1.A.) LLC
|
N/A
|
Initial (from Monitored Release)
|
05 August 2022
|
04 April 2027
|
| View |
|
BR-1220
|
Biphasic Insulin
|
Mixtard 30
|
100 IU/mL
|
Suspension for Injection (SC)
|
Prescription Drug (Rx)
|
Type I glass vial closed with a disc (bromobutyl/isoprene rubber) and a protective tamper-proof plastic cap containing 10 mL of suspension (Box of 1's)
|
Intermediate Acting Insulin
|
Novo Nordisk Production SAS
|
France
|
|
NOVO NORDISK PHARMACEUTICALS (PHILIPPINES) INC.
|
NOVO NORDISK PHARMACEUTICALS (PHILIPPINES) INC.
|
Renewal
|
31 March 2022
|
02 June 2027
|
| View |
BR-1221_PI_01.pdf
|
BR-1221
|
Adalimumab
|
Humira
|
40 mg /0.4 mL
|
Solution for Injection (SC)
|
Prescription Drug (RX)
|
Each box contains: 2 Type I pre-filled glass syringes with bromobutyl rubber plunger stopper and needle with thermoplastic elastomeric needle shield in blister pack + 2 alcohol swabs
|
Tumor Necrosis Factor Alpha (TNF-a) Inhibitors
|
Vetter Pharma-Fertigung GmbH & Co. KG
|
Germany
|
N/A
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Initial (from Monitored Release)
|
05 August 2022
|
17 July 2027
|
| View |
|
BR-1222
|
Pegfilgrastim
|
Neulastim
|
6 mg/0.6 mL
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
USP/Ph. Eur. Type I glass pre-filled syringe x 0.6 mL
with 276 0.5 inch needle (Box of 1’s)
|
-
|
Amgen Manufacturing Limited
|
U.S.A
|
N/A
|
Zuellig Pharma Corporation
|
|
-
|
18 March 2022
|
14 July 2027
|
| View |
|
BR-1223
|
Filgrastim
|
Neupogen
|
300 mcg/mL
|
Solution For Injection (SC/IV)
|
Prescription Drug (RX)
|
USP/Ph. Eur. type I glass vial x 1 mL (Box of 4's)
|
-
|
Amgen Manufacturing Limited
|
U.S.A
|
N/A
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
-
|
18 March 2022
|
14 July 2027
|
| View |
|
BR-1224
|
Filgrastim
|
Biofil
|
300 mcg/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
Single dose. USP Type I clear glass pre-filled syringe (containing 1 ml solution) with plastic plunger, rubber stopper and one hypodermic needle x 2.25 mL (Box of 1's)
|
-
|
Sinergium Biotech S.A.
|
Argentine Republic
|
Bioprofarma Bago S.A.
|
Apolloplus Capital Inc.
|
Apolloplus Capital Inc.
|
Renewal
|
26 August 2022
|
08 August 2027
|
| View |
BR-1225_PI_01.pdf
|
BR-1225
|
Insulin Degludec + Liraglutide
|
Xultophy
|
100 U/3.6 mg/mL
|
Solution for Injection (SC)
|
Prescription Drug (RX)
|
3 mL Type I glass cartridge with bromobutyl and isoprene laminate rubber and red bromobutyl rubber plunger assembled in a pen injector (Box of 5's)
|
-
|
Novo Nordisk A/S
|
Denmark
|
N/A
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Initial (from Monitored Release)
|
24 October 2022
|
10 August 2027
|
| View |
|
BR-1226
|
Insulin Detemir
|
Levemir Penfill
|
100 U/ml
|
Solution for injection
|
Prescription Drug (RX)
|
5 x 3ml cartridge
|
Insulin and analogue for injection, long-acting
|
Novo Nordisk A/S
|
Denmark
|
|
Novo Nordisk Pharmaceuticals (Philippines_ Inc.
|
|
Renewal
|
09 June 2022
|
05 September 2027
|
| View |
|
BR-1231
|
Botulinum Toxin Type A (from Clostridium botulinum)
|
Xeomin
|
100 units
|
Powder For Solution For Injection (IM)
|
Prescription Drug (RX)
|
Type I Clear glass vial (box of 1's)
|
Muscle Relaxant
|
IDT Biologika GmbH
|
Germany
|
|
Merz Philippines Healthcare Inc.
|
Merz Philippines Healthcare Inc.
|
Automatic Renewal
|
30 August 2022
|
19 September 2027
|